XDEQ:LSE:LSE-Xtrackers MSCI World Quality UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 5420

Change

+18.00 (+0.33)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+2.25 (+1.22%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.13 (+1.83%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.41%)

USD 572.76B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.09 (-0.47%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.45 (-2.01%)

USD 266.08B
0QZO:LSE 0QZO

+0.45 (+0.48%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.15 (-0.48%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

+0.57 (+0.34%)

USD 202.26B
0R24:LSE Intel Corp.

+0.26 (+1.15%)

USD 196.14B

ETFs Containing XDEQ:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.24% 73% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.24% 72% C 70% C-
Trailing 12 Months  
Capital Gain 24.40% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.40% 67% D+ 67% D+
Trailing 5 Years  
Capital Gain 78.26% 84% B 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 78.26% 83% B 84% B
Average Annual (5 Year Horizon)  
Capital Gain 13.16% N/A N/A 77% C+
Dividend Return 13.16% N/A N/A 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.10% N/A N/A 76% C+
Risk Adjusted Return 118.58% N/A N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike